Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.
2.

Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.

Tan A, Bitterman P, Sonenberg N, Peterson M, Polunovsky V.

Oncogene. 2000 Mar 9;19(11):1437-47.

3.

An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.

Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L, Schmidt EV.

Mol Cell Biol. 1996 Sep;16(9):4754-64.

4.

Translational control of the antiapoptotic function of Ras.

Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC, Bitterman PB.

J Biol Chem. 2000 Aug 11;275(32):24776-80.

5.
6.

Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth.

Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV.

J Biol Chem. 2004 Jan 30;279(5):3327-39. Epub 2003 Nov 7.

7.

eIF4E expression in tumors: its possible role in progression of malignancies.

De Benedetti A, Harris AL.

Int J Biochem Cell Biol. 1999 Jan;31(1):59-72. Review.

PMID:
10216944
9.

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.

Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI, Alitalo K.

EMBO J. 1997 Dec 15;16(24):7382-92.

10.

The role of c-myc in regulation of translation initiation.

Schmidt EV.

Oncogene. 2004 Apr 19;23(18):3217-21. Review.

PMID:
15094771
11.

eIF4E--from translation to transformation.

Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N.

Oncogene. 2004 Apr 19;23(18):3172-9.

PMID:
15094766
12.

eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.

Graff JR, Konicek BW, Lynch RL, Dumstorf CA, Dowless MS, McNulty AM, Parsons SH, Brail LH, Colligan BM, Koop JW, Hurst BM, Deddens JA, Neubauer BL, Stancato LF, Carter HW, Douglass LE, Carter JH.

Cancer Res. 2009 May 1;69(9):3866-73. doi: 10.1158/0008-5472.CAN-08-3472. Epub 2009 Apr 21.

13.
14.

Translational regulation of the mammalian growth-related protein P23: involvement of eIF-4E.

Bommer UA, Lazaris-Karatzas A, De Benedetti A, Nürnberg P, Benndorf R, Bielka H, Sonenberg N.

Cell Mol Biol Res. 1994;40(7-8):633-41.

PMID:
7787881
15.

Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis.

Li S, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Polunovsky VA, Bitterman PB.

J Biol Chem. 2004 May 14;279(20):21312-7. Epub 2004 Feb 27.

16.

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.

Demosthenous C, Han JJ, Stenson MJ, Maurer MJ, Wellik LE, Link B, Hege K, Dogan A, Sotomayor E, Witzig T, Gupta M.

Oncotarget. 2015 Apr 20;6(11):9488-501.

17.

Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release.

Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB, Polunovsky VA.

J Biol Chem. 2003 Jan 31;278(5):3015-22. Epub 2002 Nov 18.

18.

Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo.

Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA.

Mol Cell Biol. 1999 Mar;19(3):1871-80.

19.

Regulation of cell cycle entry and G1 progression by CSF-1.

Roussel MF.

Mol Reprod Dev. 1997 Jan;46(1):11-8. Review.

PMID:
8981358
20.

Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E.

Herbert TP, Fåhraeus R, Prescott A, Lane DP, Proud CG.

Curr Biol. 2000 Jun 29;10(13):793-6.

Supplemental Content

Support Center